In the search of potent α-amylase inhibitors, we have synthesized seventeen derivatives of 2mercaptobenzimidazole bearing sulfonamide (1-17) and evaluated for their α-amylase inhibitory potential. All compounds display a variable degree of α-amylase activity having IC50 values ranging between 0.90 ± 0.05 to 11.20 ± 0.30 µM when compared with the standard drug acarbose having IC50 value 1.70 ± 0.10 µM. Compound 1, 2, 11, 12 and 14 having IC50 values 1.40 ± 0.10, 1.30 ± 0.05, 0.90 ± 0.05, 1.60 ± 0.05 and 1.60 ± 0.10 µM respectively were found many folds better than the standard drug acarbose. The remaining analogs showed good inhibitory potentials.
Introduction
α-Amylase is an enzyme (EC.3.2.1.1) that hydrolyses the α-linkage of polysaccharide such as glycogen and starch yielding the dextrin and glucose [1, 2] . α-Amylase can be found in normal serum, human saliva and urine [3] . Design of αamylase inhibitors can lead to the development of new treatment method for the metabolic disorders like obesity and type II diabetes. α-Amylase preferred for their economical bulk production and malleability for genetic manipulation [4] . α-Amylase were studied extensively due to its broad-spectrum applications in industries oscillating from food to textiles, biofuel, detergents and furthermore in elimination of environment pollutant and had been realized in ground-breaking of medicine [5, 6] . These enzyme inhibitors can slow down absorption of carbohydrates, prolonging absorption time of total carbohydrate and reducing glucose absorption which consequently reduce postprandial plasma glucose level.
Benzimidazole is widely spread nitrogen containing bicyclic aromatic heterocyclic compound.
Both natural and synthetic benzimidazole derivatives attracted scientific interest due to significant biological activities such as antifungal [7] , anti-inflammatory [8] , analgesic [9] , antibacterial [10] , CNS depressant [11] , anti-HIV [12] and anthelmintic [13] .
2-Mercaptobezimidazole derivatives are one of the most important class of benzimidazole derivatives display a diverse range of interesting biological activities like neutropic [14] , analgesic [15] and antihistamine [16] activities. Similarly, sulfone moiety is also the basic functional group and have a variety of biological activities like antibacterial [17] , antitumor [18] , anti-inflammatory [19] and anhydrase inhibitory [20] activities.
Our research group is continuously in struggle to design and synthesized various heterocyclic scaffold in search of potent therapeutics. In this regard we have already reported various heterocyclic moiety as alpha glucosidase, alpha amylase and beta glucuronidase inhibitor [21] [22] [23] .
We have previously reported, benzimidazole derivatives as α-glucosidase inhibitors [24] , bisindole bearing sulfone as beta-glucuronidase inhibitor and piperazine sulfonamide analogs as alpha amylase inhibitor [25, 26] . Keeping in view the great biological importance of sulfone and benzimidazole, here in this study we have plan to synthesize 2-mercaptobenzimidazole bearing sulfonamide as a potent alpha amylase inhibitor. 
Chemistry
Synthesis of 2-mercaptobenzimidazole bearing sulfonamide analogs were carried out in three step.
Step-1: Step-2:
Various sulfonyl chloride was treated and refluxed with hydrazine hydrate in methanol to obtained substituted benzenesulfonohydrazide as intermediate product (II).
Scheme: synthesis of substituted benzenesulfonohydrazide
Step-3:
Intermediate product I was reacted and refluxed with intermediate product II in methanol in the presence of acetic acid to give 2-mercaptobenzimidazole bearing sulfonamide analogs (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . another phenyl ring. Greater inhibition shown by this analog is seems due to electron withdrawing substitution on both phenyl ring of the compound.
Scheme-1: Synthesis of 2-marcaptobenzimidazole bearing sulfonamide analogs (1-17)
If we compare compound 1 (IC50 = 1.40 ± 0.10 µM) having a methoxy group at 6-position of the benzimidazole phenyl ring, 3-nitro group on one phenyl ring and 2-methyl ring on second phenyl The least active compound among the series is analog 8 having bromine substitution on phenyl ring. Although bromine is electron withdrawing group but due to its larger size it might cause steric hindrance which results ultimately in the decline of inhibitory potential of these analogs. It was concluded from the study that nature, position and number of substituents play role in this inhibition.
Docking study
By using Gold molecular docking software, all synthesized derivatives in this series were docked into active site of target enzyme amylase (pdb: 4W93). The key connections recognized by active analogs were within 4Å radius on the binding site of amylase, were considered as most influential factor for activity. All 17 analogs in this series were active ranging from IC50 = 0.90 -11.20 µM.
Here we reveal binding mode of four active analogs (11, 2, 1 and 12). The interactive site and the binding mode of standard acarbose had been reported in our previous paper [27] .
Compound 11 is most active compound in this series and binding mode exhibit that nitro group attached to the meta position of phenyl ring of this compound is most influential in stabilizing the complex and this nitro moiety forms hydrogen bond with ASP197 and HIS299, also forms 7 electrostatic interaction with ARG195 and GLU233, also forms π-cation interaction with TYR62.
Moreover, the benzimidazole ring forms π-π stacking with HIS201 and π-Alkyl interaction with LEU162 and LYS200. In addition, the ring also forms hydrophobic contact with ILE235. The other stretches of the molecule bearing fluoro group at ortho and para of the phenyl ring forms π-π stacking with the TRP59 (Fig-2a ).
Fig-2b
exhibit the binding mode of the compound 2, residue ASP300 and ASP356 forms electrostatic interaction with benzimidazole nitrogen and the methoxy group behaves as acceptor to form hydrogen bond with ASP356. The benzimidazole ring also forms -π stacking with HIS305.
The residue ILE235 forms π-sigma interaction with the nitro phenyl ring. Toluene ring of the analog forms -π stacking with HIS201 and π-alkyl interaction with LYS200, ILE235, TYR151, ALA198 and ALA307.
Fig. 2c
represents the binding mode of the compound 1, a hydrogen bond is established between ASP197 and nitro group attached to the phenyl ring forms π-cation interaction with the TYR62, while the GLU233 forms electrostatic interaction with nitro group. Additionally, toluene ring forms π-alkyl interaction with LYS200 and π-π stacking with HIS201 and hydrophobic interaction with ILE235. On the other hand, the benzimidazole ring also forms π-π stacking with TRP59.
Finally, the binding mode orientation of the compound 12 exhibit the formation of hydrogen bond of sulfonyl group with ASP197 and HIS299. The ortho-para fluoro moieties on phenyl ring behaves as hydrogen bond acceptor for ASP197 and TRP59. The same ring also forms ππ stacking with TYR62. Likewise, the diphenyl ring forms ππ stacking with HIS305. Finally, the benzimidazole ring was also found to form ππ stacking TRY151 and π-alkyl interaction with LYS200 and hydrophobic contact with ILE235 ( Fig. 2d) .
In general docking studies, shows that the presence aromatic ring of this series forms π-π stacking and π-Alkyl interaction followed by hydrogen bond that were influential to stabilize the complex and reflects in the biological activity index. 
CONCUSION:
In conclusion, we have synthesized seventeen compounds of 2-mercaptobenzimidazole bearing sulfonamide, characterized through 1 H, 13 
Synthesis of substituted benzenesulfonohydrazide
Synthesis of 2-marcaptobenzimidazole bearing sulfonamide analogs
Intermediate product (I) was reacted and refluxed with intermediate product (II) in methanol in the presence of acetic acid to give 2-mercaptobenzimidazole bearing sulfonamide analogs (1-17). N'-(2-((6-methoxy-1H-benzo[d]imidazol-2-yl)thio)-1-(4-nitrophenyl) N'-(2-((1H-benzo[d]imidazol-2-yl)thio)-1-([1,1'-biphenyl]-4-yl) 
N'-(2-((6-methoxy-1H-benzo[d]imidazol-2-yl)thio)-1-(3-nitrophenyl)ethylidene)-2-

N'-(2-((1H-benzo[d]imidazol-2-yl)thio)-1-([1,1'-biphenyl]-4-yl)ethylidene)-2-
chlorobenzenesulfonohydrazide (4)
Yield: 71 %; 1 
N'-(2-((1H-benzo[d]imidazol-2-yl)thio)-1-(4-bromophenyl)ethylidene)-4-
methoxybenzenesulfonohydrazide (5)
Yield: 68 %; 1 HNMR (500 MHz, DMSO-d6): δ 8.17 (d, J = 6.95, 2H, Ar), 7.9 (d, J = 6.9, 2H, Ar), 
N'-(2-((1H-benzo[d]imidazol-2-yl)thio)-1-([1,1'-biphenyl]-4-yl)ethylidene)-2bromobenzenesulfonohydrazide (6)
Yield: 75 %; 1 N'-(2-((1H-benzo[d]imidazol-2-yl)thio)-1-([1,1'-biphenyl]-4-yl) N'-(2-((1H-benzo[d]imidazol-2-yl)thio)-1-(4-bromophenyl) N'-(2-((1H-benzo[d]imidazol-2-yl)thio)-1-(4-methoxyphenyl) N'-(2-((1H-benzo[d]imidazol-2-yl)thio)-1-(4-nitrophenyl) N'-(2-((1H-benzo[d]imidazol-2-yl)thio)-1-(3-nitrophenyl) N'-(1-([1,1'-biphenyl]-4-yl)-2-((6-methoxy-1H-benzo[d] N'-(2-((1H-benzo[d]imidazol-2-yl)thio)-1-(4-bromophenyl) N'-(2-((1H-benzo[d]imidazol-2-yl)thio)-1-(3-nitrophenyl) 
4.3.8.
4.3.12.
N'-(2-((1H-benzo[d]imidazol-2-yl)thio)-1-(2,5-dimethoxyphenyl)ethylidene)-2-
nitrobenzenesulfonohydrazide ( N'-(2-((1H-benzo[d]imidazol-2-yl)thio)-1-(4-bromophenyl) 
N'-(2-((1H-benzo[d]imidazol-2-yl)thio)-1-(4-nitrophenyl)ethylidene)-2-
Assay protocol for α-Amylase activity
To determine α-amylase inhibitory activity Zhang and coworker method with a slight modification was used [28, 29] . In 1. 
Docking study protocol
Docking study was done targeting the crystal structure of amylase (PDB ID: 4W93) [30] in order to reveal the binding modes of synthesized derivatives (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . For the purpose of docking studies, protein preparation module in discovery studio 2018 (Dassault systemes BIOVIA, USA) was used to optimize the crystal structure of amylase [31] . From protein data bank (PDB), crystal structure was retrieved and furthermore, structure was optimized by removing co-factors, hetero-atoms and H2O molecule. Charges, hydrogen bond and missing atom were computed. Built and ligand preparation module implemented in discovery studio 2018 (Dassault systems BIOVIA, USA) was used to prepared and optimized the docking study of the synthesized analogs (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Gold docking tool was used for the purpose of docking, ligand preparation comprises stereochemistry, assigning bond order and various tautomer. Moreover, by choosing centroid of complex ligand (Montbretin A), receptor grid was produced around amylase active site. Active sites were defined with a radius of 12Å around Montbretin A binding sites. By using Chem PLP scoring function, docking calculations were skilled [32] . By using Discover studio visualizer, docking result was further evaluated and each derivative, binding mode was visually inspected.
